Novel functions and targets of miR-944 in human cervical cancer cells

International Journal of Cancer

Volumn 136, Issue 5, 2015, Pages E230-E241

  Xie, Hong ^a   Lee, Linkiat ^a   Scicluna, Patrick ^a   Kavak, Ersen ^b,c   Larsson, Catharina ^a   Sandberg, Rickard ^b,c   Lui, Weng Onn ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

Author keywords

Cervical cancer; Invasion; Migration; miR 944; PAR CLIP; Proliferation

Indexed keywords

MICRORNA; MICRORNA 944; UNCLASSIFIED DRUG; CARRIER PROTEIN; CROSS LINKING REAGENT; HECW2 PROTEIN, HUMAN; LUCIFERASE; MESSENGER RNA; NUCLEAR PROTEIN; S100PBP PROTEIN, HUMAN; SMALL INTERFERING RNA; TP63 PROTEIN, HUMAN; TRANSCRIPTION FACTOR; TUMOR SUPPRESSOR PROTEIN; UBIQUITIN PROTEIN LIGASE;

ARTICLE; CARCINOGENESIS; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CERVICAL CANCER CELL LINE; CONTROLLED STUDY; CROSS LINKING; FEMALE; GAIN OF FUNCTION MUTATION; GENE EXPRESSION; GENE FUNCTION; GENE TARGETING; HECW2 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOPRECIPITATION; IN VITRO STUDY; LOSS OF FUNCTION MUTATION; LUCIFERASE ASSAY; ONCOGENE; RNA SEQUENCE; S100PBP GENE; TP63 GENE; WESTERN BLOTTING; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CASE CONTROL STUDY; CELL ADHESION; CELL CYCLE; CELL MOTION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL CULTURE; UTERINE CERVIX TUMOR; WOUND HEALING;

APOPTOSIS; BLOTTING, WESTERN; CARRIER PROTEINS; CASE-CONTROL STUDIES; CELL ADHESION; CELL CYCLE; CELL MOVEMENT; CELL PROLIFERATION; CROSS-LINKING REAGENTS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOPRECIPITATION; LUCIFERASES; MICRORNAS; NUCLEAR PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN-PROTEIN LIGASES; UTERINE CERVICAL NEOPLASMS; WOUND HEALING;

EID: 84918773338     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29160     Document Type: Article

References (22)

1. Lee JW, Choi CH, Choi JJ, et al. Altered Micro-RNA expression in cervical carcinomas. Clin Cancer Res 2008;14:2535-42.
2. Lui WO, Pourmand N, Patterson BK, et al. Patterns of known and novel small RNAs in human cervical cancer. Cancer Res 2007;67:6031-43.
3. Martinez I, Gardiner AS, Board KF, et al. Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene 2008;27:2575-82.
4. Pereira PM, Marques JP, Soares AR, et al. Micro-RNA expression variability in human cervical tissues. PLoS One 2010;5:e11780.
5. Wang X, Tang S, Le SY, et al. Aberrant expression of oncogenic and tumor-suppressive micro-RNAs in cervical cancer is required for cancer cell growth. PLoS One 2008;3:e2557.
6. Witten D, Tibshirani R, Gu SG, et al. Ultra-high throughput sequencing-based small RNA discovery and discrete statistical biomarker analysis in a collection of cervical tumours and matched controls. BMC Biol 2010;8:58.
7. Yao Q, Xu H, Zhang QQ, et al. MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells. Biochem Biophys Res Commun 2009;388:539-42.
8. Yang YC, Shyong WY, Chang MS, et al. Frequent gain of copy number on the long arm of chromosome 3 in human cervical adenocarcinoma. Cancer Genet Cytogenet 2001;131:48-53.
9. Schmitz M, Driesch C, Jansen L, et al. Non-random integration of the HPV genome in cervical cancer. PLoS One 2012;7:e39632.
10. Hafner M, Landthaler M, Burger L, et al. Transcriptomewide identification of RNA-binding protein and microRNA target sites by PAR-CLIP. Cell 2010;141:129-41.
11. Xie H, Zhao Y, Caramuta S, et al. miR-205 expression promotes cell proliferation and migration of human cervical cancer cells. PLoS One 2012;7:e46990.
12. Corcoran DL, Georgiev S, Mukherjee N, et al. PARalyzer: definition of RNA binding sites from PAR-CLIP short-read sequence data. Genome Biol 2011;12:R79.
13. Stark MS, Tyagi S, Nancarrow DJ, et al. Characterization of the Melanoma miRNAome by Deep Sequencing. PLoS One 2010;5:e9685.
14. Christensen LL, Tobiasen H, Holm A, et al. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer. Int J Cancer 2013;133:67-78.
15. Nordentoft I, Birkenkamp-Demtroder K, Agerbaek M, et al. miRNAs associated with chemo-sensitivity in cell lines and in advanced bladder cancer. BMC Med Genomics 2012;5:40.
16. Wang TY, Chen BF, Yang YC, et al. Histologic and immunophenotypic classification of cervical carcinomas by expression of the p53 homologue p63: a study of 250 cases. Hum Pathol 2001;32:479-86.
17. Helwak A, Kudla G, Dudnakova T, et al. Mapping the human miRNA interactome by CLASH reveals frequent noncanonical binding. Cell 2013;153:654-65.
18. Miyazaki K, Ozaki T, Kato C, et al. A novel HECT-type E3 ubiquitin ligase, NEDL2, stabilizes p73 and enhances its transcriptional activity. Biochem Biophys Res Commun 2003;308:106-13.
19. Muralikrishna B, Chaturvedi P, Sinha K, et al. Lamin misexpression upregulates three distinct ubiquitin ligase systems that degrade ATR kinase in HeLa cells. Mol Cell Biochem 2012;365:323-32.
20. Rossi M, Aqeilan RI, Neale M, et al. The E3 ubiquitin ligase Itch controls the protein stability of p63. Proc Natl Acad Sci USA 2006;103:12753-8.
21. Dowen SE, Crnogorac-Jurcevic T, Gangeswaran R, et al. Expression of S100P and its novel binding partner S100PBPR in early pancreatic cancer. Am J Pathol 2005;166:81-92.
22. Lines KE, Chelala C, Dmitrovic B, et al. S100Pbinding protein, S100PBP, mediates adhesion through regulation of cathepsin Z in pancreatic cancer cells. Am J Pathol 2012;180:1485-94.